急性心不全と鉄欠乏症で入院した患者の静脈内鉄療法: 系統的レビューとメタ解析
Victor Lopez1, Melissa Chacón2, María Jesús Arias2
1Hospital Medicine, Sinai Hospital of Baltimore, Baltimore, USA.
Cureus
|September 2, 2025
まとめ
鉄欠乏症 (ID) の急性心不全 (AHF) の場合,静脈内鉄はヘモグロビン濃度を有意に改善するが,再入院や死亡率を低下させない. 臨床的効果を確認するには,より大きな試験が必要である.
科学分野:
- 心臓病科
- 血液学
背景:
- 慢性心不全 (HF) の治療には,静脈内 (IV) 鉄を投与することが推奨されています.
- 鉄欠乏症 (ID) による急性心不全 (AHF) の効用は確立されず,議論されている.
- AHFにおけるIV鉄に関する既存の研究は,議論の余地のある結果をもたらした.
研究 の 目的:
- AHFとIDで入院した患者におけるIV鉄の臨床効果に関する証拠を体系的に検討し,メタ分析する.
- この集団におけるIV鉄の使用に関する臨床的意思決定を導くための堅実なデータを提供すること.
主な方法:
- ランダム化制御試験 (RCT) と観察研究の体系的レビューとメタ解析.
- 2024年7月1日までのPubMed,Embase,Scopus,Cochraneのデータベースを検索しました
- 再入院,死亡率,およびヘモグロビン変化に関する95%信頼区間 (CI) を有する総合リスク比 (RRs) と平均差 (MDs) です.
主要な成果:
- 3つのRCTと6つの観察研究では,3588人の患者が参加し,1622人がIVで鉄を投与された.
- IV 鉄はヘモグロビン濃度を有意に増加させた (MD = 0. 80; 95% CI = 0. 33 - 1. 27; p = 0. 0003).
- HF再入院 (RR = 0. 96; p = 0. 74),すべての原因による再入院 (RR = 1.03; p = 0. 64),またはすべての原因による死亡率 (RR = 1. 00; p = 0. 87) の統計的に有意な減少は観察されなかった.
結論:
- IV 鉄はAHFとIDの患者でヘモグロビンのレベルを効果的に改善します.
- 現在の証拠は,IV鉄がAHFの再入院または死亡率を減らすことに有意な影響を及ぼすことを支持していません.
- 大規模で高品質なRCTは,AHFにおけるIV鉄の臨床結果を決定的に評価するために必要である.
関連する概念動画
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42


